Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

The Journal of clinical investigation - 1 Oct 2008

Skowera Ania, Ellis Richard J, Varela-Calviño Ruben, Arif Sefina, Huang Guo Cai, Van-Krinks Cassie, Zaremba Anna, Rackham Chloe, Allen Jennifer S, Tree Timothy I M, Zhao Min, Dayan Colin M, Sewell Andrew K, Unger Wendy W, Unger Wendy, Drijfhout Jan W, Ossendorp Ferry, Roep Bart O, Peakman Mark

Abstract excerpt

The final pathway of beta cell destruction leading to insulin deficiency, hyperglycemia, and clinical type 1 diabetes is unknown. Here we show that circulating CTLs can kill beta cells via recognition of a glucose-regulated epitope. First, we identified 2 naturally processed epitopes from the hum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8-Positive T-Lymphocytes
Share to Diabetes Mellitus, Type 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes, T-Lymphocyte

Share to Glucose

Share to Insulin-Secreting Cells

Share to K562 Cells

Share to Protein Precursors

Share to Protein Sorting Signals

Source

Open in PubMed Open full text

Identifiers

PMID: 18802479
DOI: 10.1172/JCI35449
PMCID: PMC2542849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18802479-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.PMID 18802479Read ↗

Circulating Preproinsulin Signal Peptide–Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-CellsSemantic proximity Read ↗

Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 Diabetes.Semantic proximity Read ↗

HLA class I epitope discovery in type 1 diabetes.Semantic proximity Read ↗

Human islet T cells are highly reactive to preproinsulin in type 1 diabetesSemantic proximity Read ↗

Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.Semantic proximity Read ↗

HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome.Semantic proximity Read ↗

Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer–Restricted CD4+ T Cells Infiltrate Islets in Type 1 DiabetesSemantic proximity Read ↗

Peptides Derived From Insulin Granule Proteins Are Targeted by CD8+ T Cells Across MHC Class I Restrictions in Humans and NOD MiceSemantic proximity Read ↗

Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides.Semantic proximity Read ↗

Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ DonorsSemantic proximity Read ↗

Progress and challenges for treating Type 1 diabetes.Semantic proximity Read ↗

Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.